Sometimes the finest things in life happen by coincidence, when we happen to be in the right location at the right moment. Now, Japanese researchers have discovered a method to ensure that new treatments are delivered to the proper area in the body and at the right moment in illness progress
New Delhi [India], February 23 (ANI/PNN): KnowDis and IIT Delhi's Yardi School of Artificial Intelligence are collaborating to develop cutting-edge Artificial Intelligence models that can discover potential antibodies for treating various kinds of diseases. The collaboration involves two ren
By 2020, there will be more than 55 million cases of Alzheimer's disease worldwide, predicts Alzheimer's Disease International. Every 20 years, this number will almost double, rising to 78 million in 2030 and 139 million in 2050.
In Alzheimer's disease, a small protein known as amyloid beta misfolds to intermediates that aggregate into larger macromolecular structures known as fibrils and plaques
Amid the resurgence in Covid cases, China's indigenous vaccines, "CanSino" and "BBIBPCorV," were heavily scrutinized based on their efficacy rates. There were concerns about the legitimacy of these vaccines raised concerns after certain documents were leaked online, labeled "extra urgent and
Before World Cancer Day (4 February), a new study from the University of Southampton's Centre for Cancer Immunology demonstrated that altering how tightly an antibody attaches to a target could enhance cancer therapies.
Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
The most recent study clarifies how Pfizer and Moderna mRNA boosters influence the persistence of our Covid-19 antibodies. According to the researchers, a booster produced more durable antibodies in all individuals, including those who had recovered from a Covid-19 infection.
Patients with Antiphospholipid syndrome (APS0, an autoimmune disease that preferentially affects women, are typically given different medications to reduce their risk of blood clotting and help normalize lab values such as platelet count. Despite this, patients sometimes internally feel that
New research from the University of Virginia School of Medicine speaks to the benefits of a Covid-19 booster. The new findings shed light on how mRNA boosters - both Pfizer and Moderna - affect the durability of our antibodies to Covid-19. A booster, the researchers report, made for longer-l
The microscopic biological structures known as germinal centres are the immune system's weapons-development facilities if B cells are the immune system's munitions manufacturers, producing antibodies to eliminate hazardous infections.
People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from COVID-19. Furthermore, several cancer treatments cause these individuals to develop little or no antibodies against SARS-CoV-2 after COVID-19 vaccination.